BIND Biosciences, Inc — Form D

BIND Biosciences, Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-22. The offering totals $47.3M, of which $25.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Paul BurgessExecutive OfficerPENNSAUKEN, NJ
Andrea FranzExecutive OfficerConcord, NH
Edward SchnipperExecutive OfficerGrand Prairie, TX
James WrightExecutive OfficerDover, DE
Peter Barton HuttDirectorSalt Lake City, UT
Daniel KoerwerExecutive OfficerWalthum, MA
Amir H NashatDirectorBoston, MA
Daniel S LynchDirectorCambridge, MA
Scott MinickDirectorSunnyvale, CA
Scott MinickExecutive OfficerSunnyvale, CA
Robert S LangerDirectorNewton, MA
Omid FarokhzadDirectorBoston, MA
Noubar AfeyanDirectorCambridge, MA
Omid C FarokhzadDirectorWatertown, MA
Robert S Langer, Jr.DirectorWatertown, MA
Stephen ZaleExecutive OfficerCambridge, MA
Jeffrey HrkachExecutive OfficerCambridge, MA
Robert Barton Langer, Jr.DirectorCambridge, MA
Yuriy H UdaltsovDirectorCambridge, MA
Andrew S HirschExecutive OfficerCambridge, MA
Jeffrey H HrkachExecutive OfficerCambridge, MA
Andrea H FranzExecutive OfficerCambridge, MA
Amir S NashatDirectorCambridge, MA
Jim WrightExecutive OfficerCambridge, MA
Ed SchnipperExecutive OfficerCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2013-02-08D$20.3M$8.7M
2011-10-13D$4.8M$4.8M
2010-06-29D$12.4M$12.4M

More